Autolus Therapeutics (AUTL) Profit After Tax (2017 - 2025)

Autolus Therapeutics (AUTL) has 9 years of Profit After Tax data on file, last reported at -$90.3 million in Q4 2025.

• For the quarter ending Q4 2025, Profit After Tax fell 227.74% year-over-year to -$90.3 million; the trailing twelve-month figure through Dec 2025 stood at -$287.5 million (down 30.29% YoY), and the FY2025 full-year result was -$287.5 million, down 30.3% from the prior year.
• Profit After Tax for Q4 2025 stood at -$90.3 million, down from -$79.1 million in the prior quarter.
• Across five years, Profit After Tax topped out at $42.8 million in Q3 2022 and bottomed at -$242.5 million in Q4 2021.
• The 5-year median for Profit After Tax is -$45.7 million (2023), against an average of -$38.4 million.
• The widest annual swing landed in 2022, when Profit After Tax jumped 88.89%; it then plunged 232.35% in 2024.
• A 5-year view of Profit After Tax shows it stood at -$242.5 million in 2021, then surged by 88.89% to -$26.9 million in 2022, then slumped by 186.47% to -$77.2 million in 2023, then surged by 64.28% to -$27.6 million in 2024, then tumbled by 227.74% to -$90.3 million in 2025.
• The last three Profit After Tax figures came in at -$90.3 million (Q4 2025), -$79.1 million (Q3 2025), and -$47.9 million (Q2 2025), per Business Quant data.

Peer Comparison